All indicators are calculated by the TTM method 2
Alector, Inc. operates as a clinical stage biopharmaceutical company. The company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders.
1. There may be a delay in updating the share price
2. TTM (Trailing Twelve Months) - The sum of the company's performance in the last 12 consecutive months. The 12 months under consideration do not necessarily have to coincide with the end of the financial year. Let's assume that the company has a report for the 2nd quarter. Based on the data from Q2, as well as the three preceding quarters (Q1 of the same year and Q3, Q4 of the previous year), we get the TTM data we need. For example, TTM revenue = the sum of the company's revenue for the last 4 quarters.
The information on Dastocks.com is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy, or in any other way. Dastocks will not accept liability for any loss or damage, including without limitation any loss of profit, which may arise directly or indirectly from use of or reliance on the information on Dastocks.com. The Authors may buy and sell securities before and after any particular article and/or information herein is published.
You must accept the terms and conditions if you wish to continue to use the Dastocks website.